These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 7858736)
21. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease. Bossowski A; Stasiak-Barmuta A; Urban M Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002 [TBL] [Abstract][Full Text] [Related]
22. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200 [TBL] [Abstract][Full Text] [Related]
23. Distinctive response of thyroid-infiltrating mononuclear cells to B cell activation through CD40 and interleukin-4 in Graves' patients. Itoh M; Uchimura K; Yamamoto K; Makino M; Imamura S; Kobayashi T; Fujiwara K; Kato T; Hayakawa N; Sawai Y; Nagasaka A; Iwase K; Nomura T; Hagino Y Cytokine; 2002 Aug; 19(3):107-14. PubMed ID: 12242076 [TBL] [Abstract][Full Text] [Related]
24. Increase in peripheral natural killer cell activity in patients with autoimmune thyroid disease. Hidaka Y; Amino N; Iwatani Y; Kaneda T; Nasu M; Mitsuda N; Tanizawa O; Miyai K Autoimmunity; 1992; 11(4):239-46. PubMed ID: 1581468 [TBL] [Abstract][Full Text] [Related]
25. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy. Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139 [TBL] [Abstract][Full Text] [Related]
26. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. III. Defective interleukin-2 production by T-helper and natural killer cells. Chang WC; Fujimiya Y; Casteel N; Pattengale P Int J Cancer; 1989 Apr; 43(4):591-7. PubMed ID: 2522912 [TBL] [Abstract][Full Text] [Related]
27. Characterization of the natural killer cell activity in Hashimoto's and Graves' diseases. Pedersen BK; Feldt-Rasmussen U; Bech K; Perrild H; Klarlund K; Høier-Madsen M Allergy; 1989 Sep; 44(7):477-81. PubMed ID: 2817303 [TBL] [Abstract][Full Text] [Related]
28. Thymostimulin increases natural cytotoxic activity in patients with breast cancer. Meneses G; Delgado MA; Perez-Machado MA; Prieto A; Alonso R; Carrion F; Lanzos E; Alvarez-Mon M Int J Immunopharmacol; 1997 Apr; 19(4):187-93. PubMed ID: 9373769 [TBL] [Abstract][Full Text] [Related]
29. Interleukin 2-activated killer cells do not mediate autologous thyrocyte lysis in autoimmune thyroid disease in vitro. Matsubayashi S; Akasu F; Kasuga Y; Jamieson C; Volpé R Thyroid; 1991; 1(2):151-6. PubMed ID: 1822361 [TBL] [Abstract][Full Text] [Related]
31. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179 [TBL] [Abstract][Full Text] [Related]
32. The role of the IL-23/IL-17 axis in the pathogenesis of Graves' disease. Zheng L; Ye P; Liu C Endocr J; 2013; 60(5):591-7. PubMed ID: 23327801 [TBL] [Abstract][Full Text] [Related]
33. Immunological features of sporadic multinodular goiter. Corrales JJ; Orfao A; Miralles JM; López-Berges MC; García LC; González M; Mories MT; San Miguel J Clin Investig; 1993 Jul; 71(7):552-8. PubMed ID: 8374249 [TBL] [Abstract][Full Text] [Related]
34. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases? Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112 [TBL] [Abstract][Full Text] [Related]
35. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease. Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751 [TBL] [Abstract][Full Text] [Related]
36. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease. Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880 [TBL] [Abstract][Full Text] [Related]
37. HIV infection and natural killer cytotoxicity in hemophilic patients. de la Barrera SS; Olabuenaga SE; Soria A; Felippo M; Perez Bianco R; de Bracco MM Immunol Lett; 1990 Jun; 24(3):207-15. PubMed ID: 2384263 [TBL] [Abstract][Full Text] [Related]
38. Natural killer cell cytotoxicity is not regulated by folic acid in vitro. Hirsch S; Miranda D; Muñoz E; Montoya M; Ronco AM; de la Maza MP; Bunout D Nutrition; 2013 May; 29(5):772-6. PubMed ID: 23313250 [TBL] [Abstract][Full Text] [Related]
39. [Relationship between OX40/4-1 BB (CD134/CD137) costimulatory molecules expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease]. Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):133-40. PubMed ID: 16232366 [TBL] [Abstract][Full Text] [Related]
40. [Effects of Astragalus membranaceus and Tripterygium hypoglancum on natural killer cell activity of peripheral blood mononuclear in systemic lupus erythematosus]. Zhao XZ Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Nov; 12(11):669-71, 645. PubMed ID: 1301849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]